A

Agios (AGIO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Agios (AGIO)

Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more

  • USD23.26
  • USD23.57
  • USD22.53
  • USD34.76
  • -10.90%
  • 14M
  • 572.45k
  • 570.34k
  • 1.2B
  • 16.75
  • -20.90%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.